You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fatty Liver Nonalcoholic nondiabetic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NAFLD Trial in Cairo (Lubiprostone 24Mcg Oral Cap)

Recruiting
  • NAFLD
  • Lubiprostone 24Mcg Oral Cap
  • Cairo, Egypt
    National Hepatology and Tropical Medicine Research Institute
Mar 2, 2023

Non-alcoholic Fatty Liver Disease Trial in Zagazig (Rybelsus Oral Product, Ozempic Injectable Product, Tocopherol and/or Actos)

Recruiting
  • Non-alcoholic Fatty Liver Disease
  • Rybelsus Oral Product
  • +2 more
  • Zagazig, Sharkia, Egypt
    Zagazig University
Apr 1, 2023

Heart Failure With Preserved Ejection Fraction, Non Alcoholic Fatty Liver Trial in Sohag (echocardiography)

Not yet recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Non Alcoholic Fatty Liver
  • echocardiography
  • Sohag, El Monshah, Egypt
  • +1 more
Apr 7, 2023

Non-Alcoholic Fatty Liver Disease Trial in Seoul (GODEX, Placebo)

Enrolling by invitation
  • Non-Alcoholic Fatty Liver Disease
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 30, 2023

Type 2 Diabetes, Non Alcholic Fatty Liver Disease Trial (Bempedoic acid)

Not yet recruiting
  • Type 2 Diabetes
  • Non Alcholic Fatty Liver Disease
  • Bempedoic acid
  • (no location specified)
Sep 14, 2023

NAFLD, Nonalcoholic Fatty Liver, NASH - Nonalcoholic Steatohepatitis Trial (LUM-201)

Recruiting
  • NAFLD
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 26, 2022

Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

Completed
  • Nonalcoholic Fatty Liver Disease
  • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
  • +3 more
  • Jerusalem, Israel
    Hadassah University Hospital - Ein Kerem
Sep 13, 2023

Nonalcoholic Fatty Liver Disease Trial (Gastric Bypass Stent System in Treatment of Patients with Nonalcoholic Fatty Liver

Not yet recruiting
  • Nonalcoholic Fatty Liver Disease
  • Gastric Bypass Stent System in Treatment of Patients with Nonalcoholic Fatty Liver Disease
  • (no location specified)
Aug 8, 2022

Observational Study About Patients Diagnosed With NAFLD

Recruiting
  • Nonalcoholic Fatty Liver Disease
    • Changsha, Hunan, China
      Department of Infectious Disease, Xiangya Hospital, Central Sout
    Nov 25, 2022

    Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

    Recruiting
    • Nonalcoholic Steatohepatitis
    • Taipei, Taiwan
    • +1 more
    Feb 8, 2023

    Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

    Not yet recruiting
    • Non-alcoholic Fatty Liver Disease
    • +4 more
    • (no location specified)
    May 17, 2023

    Nonalcoholic Steatohepatitis, Genetic Risk Factor Trial (ALN-PNP Dose Level 1, ALN-PNP Dose Level 2, ALN-PNP Dose Level 3)

    Not yet recruiting
    • Nonalcoholic Steatohepatitis
    • Genetic Risk Factor
    • ALN-PNP Dose Level 1
    • +3 more
    • (no location specified)
    Sep 5, 2023

    Nonalcoholic Fatty Liver Disease in HIV Database

    Recruiting
    • NAFLD
    • +2 more
      • Birmingham, Alabama
      • +7 more
      Jan 11, 2023

      Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver

      Not yet recruiting
      • Nonalcoholic Fatty Liver Disease
      • Endoscopic Sleeve Gastroplasty
      • Morgantown, West Virginia
        West Virginia University
      Aug 16, 2022

      Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Experimental: 4 mg/day of WY-8678 (guanabenz acetate),

      Active, not recruiting
      • Nonalcoholic Fatty Liver
      • Nonalcoholic Steatohepatitis
      • Experimental: 4 mg/day of WY-8678 (guanabenz acetate)
      • Experimental: 8 mg/day of WY-8678 (guanabenz acetate)
      • Yokohama, Kanagawa, Japan
        Yokohama City University
      Sep 25, 2022

      Type 2 Diabetes With Complication Trial in Xi'an (Canagliflozin, Pioglitazone)

      Recruiting
      • Type 2 Diabetes Mellitus With Complication
      • Xi'an, Shannxi, China
        First Affiliated Hospital Xi'an Jiaotong University
      Aug 22, 2022

      Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

      Enrolling by invitation
      • Nonalcoholic Fatty Liver Disease
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Jul 5, 2022

        Nonalcoholic Steatohepatitis

        Recruiting
        • Nonalcoholic Fatty Liver Disease (NAFLD)
        • Nonalcoholic Steatohepatitis (NASH)
        • Acoustic radiation force impulse (ARFI), magnetic resonance elastography (MRE)
        • Montréal, Quebec, Canada
          Centre Hospitalier de l'Université de Montréal
        Nov 11, 2022

        NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

        Active, not recruiting
        • Nonalcoholic Fatty Liver
        • +4 more
        • Transient Elastography
        • Boston, Massachusetts
          Joslin Diabetes Center
        Sep 16, 2022

        Nonalcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes (T2DM) Trial in Gainesville (Lanifibranor, Placebo)

        Recruiting
        • Nonalcoholic Fatty Liver Disease (NAFLD)
        • Type 2 Diabetes (T2DM)
        • Gainesville, Florida
          University of Florida
        Sep 20, 2022

        Hepatic Steatosis in MAFLD With UDFF

        Not yet recruiting
        • Fatty Liver Disease, Nonalcoholic
        • bariatric surgery (BS)
        • (no location specified)
        Oct 18, 2023

        Type 2 Diabetes With Complication Trial (Canagliflozin, Pioglitazone)

        Not yet recruiting
        • Type 2 Diabetes Mellitus With Complication
        • (no location specified)
        Jul 5, 2022

        Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)

        Active, not recruiting
        • Non-alcoholic Fatty Liver Disease
        • +5 more
        • AZD7503 Intervention
        • San Antonio, Texas
          Research Site
        Jan 13, 2023

        Nonalcoholic Steatohepatitis With Advanced Fibrosis

        Recruiting
        • Nonalcoholic Steatohepatitis
        • Standard of care
        • Richmond, Virginia
          Virginia Commonwealth University
        Jan 31, 2023

        Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)

        Not yet recruiting
        • Nonalcoholic Fatty Liver
        • Osteoporosis, Postmenopausal
        • (no location specified)
        Aug 6, 2022